Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Adhesion structures in leukemia cells and their regulation by Src family kinases

P. Röselová, A. Obr, A. Holoubek, D. Grebeňová, K. Kuželová,

. 2018 ; 12 (3) : 286-298. [pub] 20170818

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Interaction of leukemia blasts with the bone marrow extracellular matrix often results in protection of leukemia cells from chemotherapy and in persistence of the residual disease which is on the basis of subsequent relapses. The adhesion signaling pathways have been extensively studied in adherent cells as well as in mature haematopoietic cells, but the adhesion structures and signaling in haematopoietic stem and progenitor cells, either normal or malignant, are much less explored. We analyzed the interaction of leukemia cells with fibronectin (FN) using interference reflection microscopy, immunofluorescence, measurement of adherent cell fraction, real-time microimpedance measurement and live cell imaging. We found that leukemia cells form very dynamic adhesion structures similar to early stages of focal adhesions. In contrast to adherent cells, where Src family kinases (SFK) belong to important regulators of focal adhesion dynamics, we observed only minor effects of SFK inhibitor dasatinib on leukemia cell binding to FN. The relatively weak involvement of SFK in adhesion structure regulation might be associated with the lack of cytoskeletal mechanical tension in leukemia cells. On the other hand, active Lyn kinase was found to specifically localize to leukemia cell adhesion structures and a less firm cell attachment to FN was often associated with higher Lyn activity (this unexpectedly occurred also after cell treatment with the inhibitor SKI-1). Lyn thus may be important for signaling from integrin-associated complexes to other processes in leukemia cells.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19028778
003      
CZ-PrNML
005      
20190822093812.0
007      
ta
008      
190813s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1080/19336918.2017.1344796 $2 doi
035    __
$a (PubMed)28678601
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Röselová, Pavla $u a Department of Proteomics , Institute of Hematology and Blood Transfusion , U Nemocnice 1, Prague , Czech Republic.
245    10
$a Adhesion structures in leukemia cells and their regulation by Src family kinases / $c P. Röselová, A. Obr, A. Holoubek, D. Grebeňová, K. Kuželová,
520    9_
$a Interaction of leukemia blasts with the bone marrow extracellular matrix often results in protection of leukemia cells from chemotherapy and in persistence of the residual disease which is on the basis of subsequent relapses. The adhesion signaling pathways have been extensively studied in adherent cells as well as in mature haematopoietic cells, but the adhesion structures and signaling in haematopoietic stem and progenitor cells, either normal or malignant, are much less explored. We analyzed the interaction of leukemia cells with fibronectin (FN) using interference reflection microscopy, immunofluorescence, measurement of adherent cell fraction, real-time microimpedance measurement and live cell imaging. We found that leukemia cells form very dynamic adhesion structures similar to early stages of focal adhesions. In contrast to adherent cells, where Src family kinases (SFK) belong to important regulators of focal adhesion dynamics, we observed only minor effects of SFK inhibitor dasatinib on leukemia cell binding to FN. The relatively weak involvement of SFK in adhesion structure regulation might be associated with the lack of cytoskeletal mechanical tension in leukemia cells. On the other hand, active Lyn kinase was found to specifically localize to leukemia cell adhesion structures and a less firm cell attachment to FN was often associated with higher Lyn activity (this unexpectedly occurred also after cell treatment with the inhibitor SKI-1). Lyn thus may be important for signaling from integrin-associated complexes to other processes in leukemia cells.
650    _2
$a buněčná adheze $x účinky léků $x fyziologie $7 D002448
650    _2
$a dasatinib $x farmakologie $7 D000069439
650    _2
$a fibronektiny $x metabolismus $7 D005353
650    _2
$a fokální adhezní tyrosinkinasy $x metabolismus $7 D051416
650    _2
$a fokální adheze $x účinky léků $x metabolismus $7 D022001
650    _2
$a lidé $7 D006801
650    _2
$a leukemie $x farmakoterapie $7 D007938
650    _2
$a fosforylace $x účinky léků $7 D010766
650    _2
$a skupina kinas odvozených od src-genu $x účinky léků $x metabolismus $7 D019061
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Obr, Adam $u a Department of Proteomics , Institute of Hematology and Blood Transfusion , U Nemocnice 1, Prague , Czech Republic.
700    1_
$a Holoubek, Aleš $u a Department of Proteomics , Institute of Hematology and Blood Transfusion , U Nemocnice 1, Prague , Czech Republic.
700    1_
$a Grebeňová, Dana $u a Department of Proteomics , Institute of Hematology and Blood Transfusion , U Nemocnice 1, Prague , Czech Republic.
700    1_
$a Kuželová, Kateřina $u a Department of Proteomics , Institute of Hematology and Blood Transfusion , U Nemocnice 1, Prague , Czech Republic.
773    0_
$w MED00173230 $t Cell adhesion & migration $x 1933-6926 $g Roč. 12, č. 3 (2018), s. 286-298
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28678601 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190822094050 $b ABA008
999    __
$a ok $b bmc $g 1433927 $s 1067238
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 12 $c 3 $d 286-298 $e 20170818 $i 1933-6926 $m Cell adhesion & migration $n Cell Adh Migr $x MED00173230
LZP    __
$a Pubmed-20190813

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...